Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Rectal Cancer Therapeutics Revenue 1.4 Market Analysis by Type 1.4.1 Global Rectal Cancer Therapeutics Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Medicine 1.4.3 Surgery 1.4.4 Other 1.5 Market by Application 1.5.1 Global Rectal Cancer Therapeutics Market Share by Application: 2020 VS 2026 1.5.2 Hospital 1.5.3 Clinic 1.5.4 Other 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Rectal Cancer Therapeutics Market Perspective (2015-2026) 2.2 Rectal Cancer Therapeutics Growth Trends by Regions 2.2.1 Rectal Cancer Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Rectal Cancer Therapeutics Historic Market Share by Regions (2015-2020) 2.2.3 Rectal Cancer Therapeutics Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Rectal Cancer Therapeutics Market Growth Strategy 2.3.6 Primary Interviews with Key Rectal Cancer Therapeutics Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Rectal Cancer Therapeutics Players by Market Size 3.1.1 Global Top Rectal Cancer Therapeutics Players by Revenue (2015-2020) 3.1.2 Global Rectal Cancer Therapeutics Revenue Market Share by Players (2015-2020) 3.1.3 Global Rectal Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Rectal Cancer Therapeutics Market Concentration Ratio 3.2.1 Global Rectal Cancer Therapeutics Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Rectal Cancer Therapeutics Revenue in 2019 3.3 Rectal Cancer Therapeutics Key Players Head office and Area Served 3.4 Key Players Rectal Cancer Therapeutics Product Solution and Service 3.5 Date of Enter into Rectal Cancer Therapeutics Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Rectal Cancer Therapeutics Historic Market Size by Type (2015-2020) 4.2 Global Rectal Cancer Therapeutics Forecasted Market Size by Type (2021-2026) 5 Rectal Cancer Therapeutics Breakdown Data by Application (2015-2026) 5.1 Global Rectal Cancer Therapeutics Market Size by Application (2015-2020) 5.2 Global Rectal Cancer Therapeutics Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Rectal Cancer Therapeutics Market Size (2015-2020) 6.2 Rectal Cancer Therapeutics Key Players in North America (2019-2020) 6.3 North America Rectal Cancer Therapeutics Market Size by Type (2015-2020) 6.4 North America Rectal Cancer Therapeutics Market Size by Application (2015-2020) 7 Europe 7.1 Europe Rectal Cancer Therapeutics Market Size (2015-2020) 7.2 Rectal Cancer Therapeutics Key Players in Europe (2019-2020) 7.3 Europe Rectal Cancer Therapeutics Market Size by Type (2015-2020) 7.4 Europe Rectal Cancer Therapeutics Market Size by Application (2015-2020) 8 China 8.1 China Rectal Cancer Therapeutics Market Size (2015-2020) 8.2 Rectal Cancer Therapeutics Key Players in China (2019-2020) 8.3 China Rectal Cancer Therapeutics Market Size by Type (2015-2020) 8.4 China Rectal Cancer Therapeutics Market Size by Application (2015-2020) 9 Japan 9.1 Japan Rectal Cancer Therapeutics Market Size (2015-2020) 9.2 Rectal Cancer Therapeutics Key Players in Japan (2019-2020) 9.3 Japan Rectal Cancer Therapeutics Market Size by Type (2015-2020) 9.4 Japan Rectal Cancer Therapeutics Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Rectal Cancer Therapeutics Market Size (2015-2020) 10.2 Rectal Cancer Therapeutics Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Rectal Cancer Therapeutics Market Size by Type (2015-2020) 10.4 Southeast Asia Rectal Cancer Therapeutics Market Size by Application (2015-2020) 11 India 11.1 India Rectal Cancer Therapeutics Market Size (2015-2020) 11.2 Rectal Cancer Therapeutics Key Players in India (2019-2020) 11.3 India Rectal Cancer Therapeutics Market Size by Type (2015-2020) 11.4 India Rectal Cancer Therapeutics Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Rectal Cancer Therapeutics Market Size (2015-2020) 12.2 Rectal Cancer Therapeutics Key Players in Central & South America (2019-2020) 12.3 Central & South America Rectal Cancer Therapeutics Market Size by Type (2015-2020) 12.4 Central & South America Rectal Cancer Therapeutics Market Size by Application (2015-2020) 13Key Players Profiles 13.1 Eli Lilly and Company 13.1.1 Eli Lilly and Company Company Details 13.1.2 Eli Lilly and Company Business Overview and Its Total Revenue 13.1.3 Eli Lilly and Company Rectal Cancer Therapeutics Introduction 13.1.4 Eli Lilly and Company Revenue in Rectal Cancer Therapeutics Business (2015-2020)) 13.1.5 Eli Lilly and Company Recent Development 13.2 Taiwan Liposome 13.2.1 Taiwan Liposome Company Details 13.2.2 Taiwan Liposome Business Overview and Its Total Revenue 13.2.3 Taiwan Liposome Rectal Cancer Therapeutics Introduction 13.2.4 Taiwan Liposome Revenue in Rectal Cancer Therapeutics Business (2015-2020) 13.2.5 Taiwan Liposome Recent Development 13.3 Genentech 13.3.1 Genentech Company Details 13.3.2 Genentech Business Overview and Its Total Revenue 13.3.3 Genentech Rectal Cancer Therapeutics Introduction 13.3.4 Genentech Revenue in Rectal Cancer Therapeutics Business (2015-2020) 13.3.5 Genentech Recent Development 13.4 Sanofi-aventis Groupe 13.4.1 Sanofi-aventis Groupe Company Details 13.4.2 Sanofi-aventis Groupe Business Overview and Its Total Revenue 13.4.3 Sanofi-aventis Groupe Rectal Cancer Therapeutics Introduction 13.4.4 Sanofi-aventis Groupe Revenue in Rectal Cancer Therapeutics Business (2015-2020) 13.4.5 Sanofi-aventis Groupe Recent Development 13.5 Merck 13.5.1 Merck Company Details 13.5.2 Merck Business Overview and Its Total Revenue 13.5.3 Merck Rectal Cancer Therapeutics Introduction 13.5.4 Merck Revenue in Rectal Cancer Therapeutics Business (2015-2020) 13.5.5 Merck Recent Development 13.6 Bristol-Myers Squibb 13.6.1 Bristol-Myers Squibb Company Details 13.6.2 Bristol-Myers Squibb Business Overview and Its Total Revenue 13.6.3 Bristol-Myers Squibb Rectal Cancer Therapeutics Introduction 13.6.4 Bristol-Myers Squibb Revenue in Rectal Cancer Therapeutics Business (2015-2020) 13.6.5 Bristol-Myers Squibb Recent Development 13.7 Hutchison MediPharma 13.7.1 Hutchison MediPharma Company Details 13.7.2 Hutchison MediPharma Business Overview and Its Total Revenue 13.7.3 Hutchison MediPharma Rectal Cancer Therapeutics Introduction 13.7.4 Hutchison MediPharma Revenue in Rectal Cancer Therapeutics Business (2015-2020) 13.7.5 Hutchison MediPharma Recent Development 13.8 Seattle Genetics 13.8.1 Seattle Genetics Company Details 13.8.2 Seattle Genetics Business Overview and Its Total Revenue 13.8.3 Seattle Genetics Rectal Cancer Therapeutics Introduction 13.8.4 Seattle Genetics Revenue in Rectal Cancer Therapeutics Business (2015-2020) 13.8.5 Seattle Genetics Recent Development 13.9 Advaxis 13.9.1 Advaxis Company Details 13.9.2 Advaxis Business Overview and Its Total Revenue 13.9.3 Advaxis Rectal Cancer Therapeutics Introduction 13.9.4 Advaxis Revenue in Rectal Cancer Therapeutics Business (2015-2020) 13.9.5 Advaxis Recent Development 13.10 Pfizer 13.10.1 Pfizer Company Details 13.10.2 Pfizer Business Overview and Its Total Revenue 13.10.3 Pfizer Rectal Cancer Therapeutics Introduction 13.10.4 Pfizer Revenue in Rectal Cancer Therapeutics Business (2015-2020) 13.10.5 Pfizer Recent Development 13.11 AstraZeneca 10.11.1 AstraZeneca Company Details 10.11.2 AstraZeneca Business Overview and Its Total Revenue 10.11.3 AstraZeneca Rectal Cancer Therapeutics Introduction 10.11.4 AstraZeneca Revenue in Rectal Cancer Therapeutics Business (2015-2020) 10.11.5 AstraZeneca Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Rectal Cancer Therapeutics Key Market Segments Table 2. Key Players Covered: Ranking by Rectal Cancer Therapeutics Revenue Table 3. Ranking of Global Top Rectal Cancer Therapeutics Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Rectal Cancer Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Medicine Table 6. Key Players of Surgery Table 7. Key Players of Other Table 8. Global Rectal Cancer Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 9. Global Rectal Cancer Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026 Table 10. Global Rectal Cancer Therapeutics Market Size by Regions (2015-2020) (US$ Million) Table 11. Global Rectal Cancer Therapeutics Market Share by Regions (2015-2020) Table 12. Global Rectal Cancer Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 13. Global Rectal Cancer Therapeutics Market Share by Regions (2021-2026) Table 14. Market Top Trends Table 15. Key Drivers: Impact Analysis Table 16. Key Challenges Table 17. Rectal Cancer Therapeutics Market Growth Strategy Table 18. Main Points Interviewed from Key Rectal Cancer Therapeutics Players Table 19. Global Rectal Cancer Therapeutics Revenue by Players (2015-2020) (Million US$) Table 20. Global Rectal Cancer Therapeutics Market Share by Players (2015-2020) Table 21. Global Top Rectal Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rectal Cancer Therapeutics as of 2019) Table 22. Global Rectal Cancer Therapeutics by Players Market Concentration Ratio (CR5 and HHI) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Rectal Cancer Therapeutics Product Solution and Service Table 25. Date of Enter into Rectal Cancer Therapeutics Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Rectal Cancer Therapeutics Market Size by Type (2015-2020) (Million US$) Table 28. Global Rectal Cancer Therapeutics Market Size Share by Type (2015-2020) Table 29. Global Rectal Cancer Therapeutics Revenue Market Share by Type (2021-2026) Table 30. Global Rectal Cancer Therapeutics Market Size Share by Application (2015-2020) Table 31. Global Rectal Cancer Therapeutics Market Size by Application (2015-2020) (Million US$) Table 32. Global Rectal Cancer Therapeutics Market Size Share by Application (2021-2026) Table 33. North America Key Players Rectal Cancer Therapeutics Revenue (2019-2020) (Million US$) Table 34. North America Key Players Rectal Cancer Therapeutics Market Share (2019-2020) Table 35. North America Rectal Cancer Therapeutics Market Size by Type (2015-2020) (Million US$) Table 36. North America Rectal Cancer Therapeutics Market Share by Type (2015-2020) Table 37. North America Rectal Cancer Therapeutics Market Size by Application (2015-2020) (Million US$) Table 38. North America Rectal Cancer Therapeutics Market Share by Application (2015-2020) Table 39. Europe Key Players Rectal Cancer Therapeutics Revenue (2019-2020) (Million US$) Table 40. Europe Key Players Rectal Cancer Therapeutics Market Share (2019-2020) Table 41. Europe Rectal Cancer Therapeutics Market Size by Type (2015-2020) (Million US$) Table 42. Europe Rectal Cancer Therapeutics Market Share by Type (2015-2020) Table 43. Europe Rectal Cancer Therapeutics Market Size by Application (2015-2020) (Million US$) Table 44. Europe Rectal Cancer Therapeutics Market Share by Application (2015-2020) Table 45. China Key Players Rectal Cancer Therapeutics Revenue (2019-2020) (Million US$) Table 46. China Key Players Rectal Cancer Therapeutics Market Share (2019-2020) Table 47. China Rectal Cancer Therapeutics Market Size by Type (2015-2020) (Million US$) Table 48. China Rectal Cancer Therapeutics Market Share by Type (2015-2020) Table 49. China Rectal Cancer Therapeutics Market Size by Application (2015-2020) (Million US$) Table 50. China Rectal Cancer Therapeutics Market Share by Application (2015-2020) Table 51. Japan Key Players Rectal Cancer Therapeutics Revenue (2019-2020) (Million US$) Table 52. Japan Key Players Rectal Cancer Therapeutics Market Share (2019-2020) Table 53. Japan Rectal Cancer Therapeutics Market Size by Type (2015-2020) (Million US$) Table 54. Japan Rectal Cancer Therapeutics Market Share by Type (2015-2020) Table 55. Japan Rectal Cancer Therapeutics Market Size by Application (2015-2020) (Million US$) Table 56. Japan Rectal Cancer Therapeutics Market Share by Application (2015-2020) Table 57. Southeast Asia Key Players Rectal Cancer Therapeutics Revenue (2019-2020) (Million US$) Table 58. Southeast Asia Key Players Rectal Cancer Therapeutics Market Share (2019-2020) Table 59. Southeast Asia Rectal Cancer Therapeutics Market Size by Type (2015-2020) (Million US$) Table 60. Southeast Asia Rectal Cancer Therapeutics Market Share by Type (2015-2020) Table 61. Southeast Asia Rectal Cancer Therapeutics Market Size by Application (2015-2020) (Million US$) Table 62. Southeast Asia Rectal Cancer Therapeutics Market Share by Application (2015-2020) Table 63. India Key Players Rectal Cancer Therapeutics Revenue (2019-2020) (Million US$) Table 64. India Key Players Rectal Cancer Therapeutics Market Share (2019-2020) Table 65. India Rectal Cancer Therapeutics Market Size by Type (2015-2020) (Million US$) Table 66. India Rectal Cancer Therapeutics Market Share by Type (2015-2020) Table 67. India Rectal Cancer Therapeutics Market Size by Application (2015-2020) (Million US$) Table 68. India Rectal Cancer Therapeutics Market Share by Application (2015-2020) Table 69. Central & South America Key Players Rectal Cancer Therapeutics Revenue (2019-2020) (Million US$) Table 70. Central & South America Key Players Rectal Cancer Therapeutics Market Share (2019-2020) Table 71. Central & South America Rectal Cancer Therapeutics Market Size by Type (2015-2020) (Million US$) Table 72. Central & South America Rectal Cancer Therapeutics Market Share by Type (2015-2020) Table 73. Central & South America Rectal Cancer Therapeutics Market Size by Application (2015-2020) (Million US$) Table 74. Central & South America Rectal Cancer Therapeutics Market Share by Application (2015-2020) Table 75. Eli Lilly and Company Company Details Table 76. Eli Lilly and Company Business Overview Table 77. Eli Lilly and Company Product Table 78. Eli Lilly and Company Revenue in Rectal Cancer Therapeutics Business (2015-2020) (Million US$) Table 79. Eli Lilly and Company Recent Development Table 80. Taiwan Liposome Company Details Table 81. Taiwan Liposome Business Overview Table 82. Taiwan Liposome Product Table 83. Taiwan Liposome Revenue in Rectal Cancer Therapeutics Business (2015-2020) (Million US$) Table 84. Taiwan Liposome Recent Development Table 85. Genentech Company Details Table 86. Genentech Business Overview Table 87. Genentech Product Table 88. Genentech Revenue in Rectal Cancer Therapeutics Business (2015-2020) (Million US$) Table 89. Genentech Recent Development Table 90. Sanofi-aventis Groupe Company Details Table 91. Sanofi-aventis Groupe Business Overview Table 92. Sanofi-aventis Groupe Product Table 93. Sanofi-aventis Groupe Revenue in Rectal Cancer Therapeutics Business (2015-2020) (Million US$) Table 94. Sanofi-aventis Groupe Recent Development Table 95. Merck Company Details Table 96. Merck Business Overview Table 97. Merck Product Table 98. Merck Revenue in Rectal Cancer Therapeutics Business (2015-2020) (Million US$) Table 99. Merck Recent Development Table 100. Bristol-Myers Squibb Company Details Table 101. Bristol-Myers Squibb Business Overview Table 102. Bristol-Myers Squibb Product Table 103. Bristol-Myers Squibb Revenue in Rectal Cancer Therapeutics Business (2015-2020) (Million US$) Table 104. Bristol-Myers Squibb Recent Development Table 105. Hutchison MediPharma Company Details Table 106. Hutchison MediPharma Business Overview Table 107. Hutchison MediPharma Product Table 108. Hutchison MediPharma Revenue in Rectal Cancer Therapeutics Business (2015-2020) (Million US$) Table 109. Hutchison MediPharma Recent Development Table 110. Seattle Genetics Business Overview Table 111. Seattle Genetics Product Table 112. Seattle Genetics Company Details Table 113. Seattle Genetics Revenue in Rectal Cancer Therapeutics Business (2015-2020) (Million US$) Table 114. Seattle Genetics Recent Development Table 115. Advaxis Company Details Table 116. Advaxis Business Overview Table 117. Advaxis Product Table 118. Advaxis Revenue in Rectal Cancer Therapeutics Business (2015-2020) (Million US$) Table 119. Advaxis Recent Development Table 120. Pfizer Company Details Table 121. Pfizer Business Overview Table 122. Pfizer Product Table 123. Pfizer Revenue in Rectal Cancer Therapeutics Business (2015-2020) (Million US$) Table 124. Pfizer Recent Development Table 125. AstraZeneca Company Details Table 126. AstraZeneca Business Overview Table 127. AstraZeneca Product Table 128. AstraZeneca Revenue in Rectal Cancer Therapeutics Business (2015-2020) (Million US$) Table 129. AstraZeneca Recent Development Table 130. Research Programs/Design for This Report Table 131. Key Data Information from Secondary Sources Table 132. Key Data Information from Primary Sources List of Figures Figure 1. Global Rectal Cancer Therapeutics Market Share by Type: 2020 VS 2026 Figure 2. Medicine Features Figure 3. Surgery Features Figure 4. Other Features Figure 5. Global Rectal Cancer Therapeutics Market Share by Application: 2020 VS 2026 Figure 6. Hospital Case Studies Figure 7. Clinic Case Studies Figure 8. Other Case Studies Figure 9. Rectal Cancer Therapeutics Report Years Considered Figure 10. Global Rectal Cancer Therapeutics Market Size YoY Growth 2015-2026 (US$ Million) Figure 11. Global Rectal Cancer Therapeutics Market Share by Regions: 2020 VS 2026 Figure 12. Global Rectal Cancer Therapeutics Market Share by Regions (2021-2026) Figure 13. Porter's Five Forces Analysis Figure 14. Global Rectal Cancer Therapeutics Market Share by Players in 2019 Figure 15. Global Top Rectal Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rectal Cancer Therapeutics as of 2019 Figure 16. The Top 10 and 5 Players Market Share by Rectal Cancer Therapeutics Revenue in 2019 Figure 17. North America Rectal Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 18. Europe Rectal Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 19. China Rectal Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Japan Rectal Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Southeast Asia Rectal Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 22. India Rectal Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Central & South America Rectal Cancer Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Eli Lilly and Company Total Revenue (US$ Million): 2019 Compared with 2018 Figure 25. Eli Lilly and Company Revenue Growth Rate in Rectal Cancer Therapeutics Business (2015-2020) Figure 26. Taiwan Liposome Total Revenue (US$ Million): 2019 Compared with 2018 Figure 27. Taiwan Liposome Revenue Growth Rate in Rectal Cancer Therapeutics Business (2015-2020) Figure 28. Genentech Total Revenue (US$ Million): 2019 Compared with 2018 Figure 29. Genentech Revenue Growth Rate in Rectal Cancer Therapeutics Business (2015-2020) Figure 30. Sanofi-aventis Groupe Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. Sanofi-aventis Groupe Revenue Growth Rate in Rectal Cancer Therapeutics Business (2015-2020) Figure 32. Merck Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. Merck Revenue Growth Rate in Rectal Cancer Therapeutics Business (2015-2020) Figure 34. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018 Figure 35. Bristol-Myers Squibb Revenue Growth Rate in Rectal Cancer Therapeutics Business (2015-2020) Figure 36. Hutchison MediPharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 37. Hutchison MediPharma Revenue Growth Rate in Rectal Cancer Therapeutics Business (2015-2020) Figure 38. Seattle Genetics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 39. Seattle Genetics Revenue Growth Rate in Rectal Cancer Therapeutics Business (2015-2020) Figure 40. Advaxis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 41. Advaxis Revenue Growth Rate in Rectal Cancer Therapeutics Business (2015-2020) Figure 42. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 43. Pfizer Revenue Growth Rate in Rectal Cancer Therapeutics Business (2015-2020) Figure 44. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018 Figure 45. AstraZeneca Revenue Growth Rate in Rectal Cancer Therapeutics Business (2015-2020) Figure 46. Bottom-up and Top-down Approaches for This Report Figure 47. Data Triangulation Figure 48. Key Executives Interviewed

Eli Lilly and Company Taiwan Liposome Genentech Sanofi-aventis Groupe Merck Bristol-Myers Squibb Hutchison MediPharma Seattle Genetics Advaxis Pfizer AstraZeneca